$199.99
Stay ahead of regulatory changes with this in-depth course on the latest proposed federal requirements for health plan price transparency. Learn how upcoming amendments to the Public Health Service Act, ERISA, and the Internal Revenue Code will reshape reporting obligations for non-grandfathered group health plans and insurance issuers. The course covers new data elements, contextual file standards, enhanced consumer access methods, and the alignment with Executive Order 14221. Gain practical insights on compliance, operational impacts, and how these changes will affect stakeholders across the healthcare system.
In this course you will learn the following:
* Explain the goals and intent of the proposed rule.
* Identify key changes to price transparency requirements for group health plans and health insurance issuers.
* Recognize the importance of public participation and the comment process.
* Understand the potential impacts, costs, and benefits of the proposed rule.
* Anticipate how the rule may evolve based on stakeholder input.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
Why This Course is Important
If you don’t take this course, you risk falling behind on critical federal compliance updates and may miss strategies for efficient implementation, potentially resulting in regulatory penalties or operational inefficiencies.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Transparency in Coverage.
Key regulatory references include:
Course SKU
FR-25-1648-1
CourseAvenue eLearning Platform has helped Federal agencies (and their suppliers) successfully address their most complex eLearning accessibility challenges.
Why This Course is Important
Without this course, you may overlook critical FDA requirements for HSV CNS diagnostic devices, risking compliance gaps and delayed market access.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medical Devices; Immunology and Microbiology Devices; Classification of the Herpes Simplex Virus Nucleic Acid-Based Assay for Central Nervous System Infections.
Key regulatory references include:
Course SKU
FR-25-1407-1
Why This Course is Important
Without this course, professionals risk non-compliance with FDA device regulations, potentially delaying device approval, missing out on streamlined market access, and failing to implement critical safety measures that protect patients and support innovative diagnostics.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medical Devices; Hematology and Pathology Devices; Classification of the Fluorescence In Situ Hybridization-Based Detection of Chromosomal Abnormalities From Patients With Hematologic Malignancies.
Key regulatory references include:
Course SKU
FR-25-1406-1
© 2026 CourseAvenue, LLC | All rights reserved.
